Page last updated: 2024-10-31

mianserin and Phantom Limb

mianserin has been researched along with Phantom Limb in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Phantom Limb: Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tansho, K1
Nakajima-Ohyama, KC1
Watase, K1
Hida, JI1

Other Studies

1 other study available for mianserin and Phantom Limb

ArticleYear
Management of Phantom Limb Pain after Amputation by Adjunctive Use of Mianserin in a Diabetic Case on Hemodialysis: A Case Report.
    Journal of palliative medicine, 2021, Volume: 24, Issue:9

    Topics: Amputation, Surgical; Diabetes Mellitus; Humans; Mianserin; Phantom Limb; Renal Dialysis

2021